MALIGNANT MELANOMA STAGE III

This adverse event was reported 203 times

These drugs are most commonly taken by patients reporting MALIGNANT MELANOMA STAGE III:

# Drug Count
0 SILDENAFIL CITRATE 77
1 TADALAFIL 60
2 DABRAFENIB 14
3 METFORMIN 14
4 METFORMIN ER 500 MG 14
5 METFORMIN ER 750 MG 14
6 ADALIMUMAB 13
7 TRAMETINIB 13
8 LISINOPRIL 12
9 AMLODIPINE 9
See all common drugs associated with MALIGNANT MELANOMA STAGE III

MALIGNANT MELANOMA STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AMLODIPINE AND VALSARTAN 1 0.0051
1 ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE 1 0.0011
2 DABRAFENIB 14 0.0007
3 TALIMOGENE LAHERPAREPVEC 1 0.0006
4 SILDENAFIL CITRATE 77 0.0006
5 TADALAFIL 60 0.0006
6 TRAMETINIB 13 0.0005
7 UREA 1 0.0005
8 SILVER SULFADIAZINE 1 0.0004
9 CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE 1 0.0003
See all drugs enriched for association with MALIGNANT MELANOMA STAGE III